CFDE Data Portal | Search XYLT1

	Label	Description
	XYLT1 Gene (Entity type)	ENSG00000103489 - xylosyltransferase 1
	XYLT1 associations Collection (Entity type)	Associations for XYLT1_associations
	XYLT1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	XYLT1 Gene (Entity type)	xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:15516]
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 14 V 13 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

XYLT1

ENSG00000103489 - xylosyltransferase 1

XYLT1 associations

Associations for XYLT1_associations

XYLT1 associations.tsv

A file from IDG as part of the Harmonizome project

XYLT1

xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:15516]

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE233679 14 V 13 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.